Respiratory

Latest News

OTC Product Roundup: Cough, Cold, and Flu
OTC Product Roundup: Cough, Cold, and Flu

February 22nd 2024

These OTC products are recommended to address a variety of symptoms that occur during cold and flu seasons.

Sedentary Patients With COPD Face Elevated Risk of Emergency Department Visits
Sedentary Patients With COPD Face Elevated Risk of Emergency Department Visits

February 16th 2024

FDA: PDUFA Date Assigned for Arexvy as RSV Prevention in Age 50 to 59
FDA: PDUFA Date Assigned for Arexvy as RSV Prevention in Age 50 to 59

February 8th 2024

Hospitals Reinstate Mask Guidelines Against Triple Threat of Respiratory Illnesses
Hospitals Reinstate Mask Guidelines Against Triple Threat of Respiratory Illnesses

January 4th 2024

Moderna’s mRNA RSV Vaccine Shows Positive Results in Phase 3 Trial
Moderna’s mRNA RSV Vaccine Shows Positive Results in Phase 3 Trial

January 3rd 2024

Latest CME Events & Activities

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

Exploring the New Standard of Care for the Frontline Treatment of Non-Small Cell Lung Cancer: A Focus on Immunotherapy

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC

2 Credits / Oncology, Pulmonology/Respiratory

View More

Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies

3.0 Credits / Pulmonology/Respiratory

View More

Targeted Therapies for Non-Small Cell Lung Cancer With ROS1 or KRAS Mutations and the Impact of Pharmacists’ Care

1.0 Credit / Oncology, Pulmonology/Respiratory

View More

Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective

1.5 Credits / Pulmonology/Respiratory

View More

Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Reducing the Incidence and Severity of RSV in Older Adults: Opportunities for Patient Identification and Vaccination Counseling

1.0 Credit / Infectious Diseases, Pulmonology/Respiratory

View More

Exploring Recent Advances in the Treatment of COPD: An Update for Pharmacists

0.75 Credit / Pulmonology/Respiratory

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Novel Therapeutic Approaches for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer: An Oncology Pharmacy Perspective

1.0 Credit / Oncology, Pulmonology/Respiratory

View More

Practical Approaches in the Management of Pulmonary Arterial Hypertension: Understanding the Pharmacist’s Role in Personalized Care

1.0 Credit / Pulmonology/Respiratory

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency

1.0 Credit / Pulmonology/Respiratory

View More

Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults

2.0 Credits / Infectious Diseases, Respiratory, Immunization

View More

Integrating Guideline-Driven Protocols Into Evidence-Based Practice to Improve Outcomes in Patients With Pulmonary Arterial Hypertension

1.0 Credit / Respiratory

View More

GASp, Where’s the Amoxicillin? Group A Streptococcus Infections and What Pharmacists Need to Know

1.0 Credit / Pulmonology/Respiratory

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Exploring the GOLD Report Updates and the Value of Patient-Centered Strategies for the Treatment of Chronic Obstructive Pulmonary Disease: Opportunities to Reduce Health Burde...

1.0 Credit / Pulmonology/Respiratory

View More

Exploring the GOLD Report Updates and the Value of Patient-Centered Strategies for the Treatment of Chronic Obstructive Pulmonary Disease: Opportunities to Reduce Health Burde...

1.0 Credit / Pulmonology/Respiratory

View More

More News

© 2024 MJH Life Sciences

All rights reserved.